Tower Research Capital LLC (Trc) Imago Bio Sciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$15.03 - $35.96 $32,314 - $77,314	-2,150 Reduced 38.1%	3,493 $125,000
Q3 2022 Nov 10, 2022	BUY	$14.15 - $19.5 $60,137 - $82,875	4,250 Added 305.1%	5,643 $85,000
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $10,192 - $18,053	863 Added 162.83%	1,393 $19,000
Q1 2022 May 12, 2022	SELL	$16.97 - $25.0 $11,030 - $16,250	-650 Reduced 55.08%	530 $10,000
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $12,116 - $22,178	747 Added 172.52%	1,180 $28,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $6,928 - $12,487	433 New	433 $9,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.